References

Adlard, P.A., S.M. Kirov, K. Sanderson and G.E. Cox, 1998. Psedomonus aeruginosa as a cause of infectious diaerrhoea. Epidemiol. Infect., 121: 237-241.
PubMed  |  

Buret, A., M.L. Dunkley, G. Pang, R.L. Clancy and A.W. Cripps, 1994. Pulmonary immunity to Pseudomonas aeruginosa in intestinally immunized rats: role of alveolar macrophages, tumor necrotic factor and interleukin-1a. Infect. Immunity., 62: 5335-5343.
PubMed  |  Direct Link  |  

Cripps, A.W., M.L. Dunkley and R.L. Clancy, 1994. Mucosal and systemic immunizations with killed Pseudomonas aeruginosa protect against acute respiratory infection in rats. Infect. Immunity, 62: 1427-1436.
Direct Link  |  

Cripps, A.W., M.L. Dunkley, R.L. Clancy and J. Kyd, 1995. Pulmonary immunity to Pseudomonas aeruginosa. Immunol. Cell Biol., 73: 418-424.
PubMed  |  Direct Link  |  

Cruickshank, R., J.P. Duguid, B.P. Marmion and R.H.A. Swain, 1975. Medical Microbiology: The Practice of Medical Microbiology. 12th Edn., Churchill Livingstone, Edinburgh, UK., ISBN-13: 9780443011115, Pages: 587.

Davis, P.B., M. Drumm and M.W. Konstan, 1996. Cystic fibrosis. Am. J. Respir. Crit. Care Med., 154: 1229-1256.

Engel, L.S., J.M. Hill, J.M. Moreau, L.C. Green, J.A. Hobden and R.J. O'Callghan, 1998. Pseudomonas aeruginosa protease IV produces corneal damage and contributes to bacterial virulence. Invest. Opthalmol. Vis. Sci., 39: 662-665.
Direct Link  |  

Fleiszig, S.M.J. and D.J. Evans, 2002. The pathogenesis of bacterial keratitis: Studies with Pseudomonas aeruginosa. Clin. Exp. Optomet., 85: 271-276.
Direct Link  |  

Foxwell, A.R., J.M. Kyd and A.W. Cripps, 1998. Charecterization of immunological response in clearance of nontypable Haemophilus influenzae from the lung. Immunol. Cell Biol., 76: 323-331.
CrossRef  |  Direct Link  |  

Gilligan, P.H., 1991. Microbiology of airway disease in patients with cystic fibrosis. Clin. Micriol. Rev., 4: 35-51.
Direct Link  |  

Hazlett, L.D., 2004. Corneal response to Pseudomonas aeruginosa infection. Progress Retinal. Eye Res., 23: 1-30.
Direct Link  |  

Hazlett, L.D., Q. Li, J. Liu, S. McClellan, W. Du and R.P. Barret, 2007. NKT cells are critical to initiate an inflammatory response after Pseudomonas aeruginosa ocular infection in susceptible mice. J. Immunol., 179: 1138-1146.
Direct Link  |  

Hazlett, L.D., S.A. McClellan, R.P. Barret, X. Huang and Y. Zhang et al., 2010. IL-33 shifts macrophage polarization, promoting resistance against Pseudomonas aeruginosa keratitis. Invest. Ophthalmol. Vis. Sci., 51: 1524-1532.
CrossRef  |  

Hemachandra, S., K. Kamboj, J. Copfer, G. Pier, L.L. Green and J.R. Schreiber, 2001. Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal Pseudomonas sepsis. Infect. Immunity, 69: 2223-2229.
Direct Link  |  

Inoue, Y., Y. Ohashi, Y. Shimomura, R. Manabe, M. Yamada, S. Ueda and S. Kato, 1990. Herpes simplex virus glycoprotein D. protective immunity against murine herpetic keratitis. Invest. Ophthaloml. Vis. Sci., 31: 411-418.
Direct Link  |  

Jang, I.J., I.S. Kim, W.J. Park, K.S. Yoo and D.S. Yim et al., 1999. Human immune response to a Pseudomonas aeruginosa outer membrane protein vaccine. Vaccine, 17: 158-168.
Direct Link  |  

Kiernan, J.A., 1999. Histological and Histochemical Methods: Theory and Practice. 3rd Edn., Butterworth Heinemann Publication, Oxford, Pages:112.

Kreger, A.S., D.M. Lyerly, L.D. Hazlett and R.S. Berk, 1986. Immunization against experimental Pseudomonas aeruginosa and Serratia marcescens keratitis. vaccination with lipopolysaccharide endotoxins and proteases. Invest. Ophthalmol. Vis. Sci., 27: 932-939.
Direct Link  |  

Masinick, S.A., C.P. Montgomery, P.C. Montgomery and L.D. Hazlett, 1997. Secretory IgA inhibits Pseudomonas aeruginosa binding to cornea and protects against keratitis. Invest. Ophthalmol. Vis. Sci., 38: 910-918.
Direct Link  |  

Miyazaki, S., T. Matsumoto, K. Tateda, A. Ohno and K. Yamaguchi, 1995. Role of exotoxin A in inducing severe Pseudomonas aeruginosa infection in mice. J. Med. Microbiol., 43: 169-175.
CrossRef  |  Direct Link  |  

Moon, M.M., L.D. Hazlett, R.E.W. Hancock, R.S. Berk and R. Barrett, 1988. Monoclonal antibodies provided protection against ocular Pseudomonas aeruginosa infection. Invest. Ophthalmol. Vis. Sci., 29: 1277-1284.
Direct Link  |  

Mun, J.J., C. Tam, D. Kowbel, S. Hawgood, M.J. Barnett, D.J. Evans and S.M.J. Fleiszig, 2009. Clearance of Pseudomonas aeruginosa from a healthy ocular surface involves surfactant protein D and is compromised by bacterial elastase in a murine null-infection model. Infect. Immunity, 77: 2392-2398.
Direct Link  |  

O'Callaghan, R.J., L.S. Engel, J.A. Hobden, M.C. Callegan, L.C. Green and J.M. Hill, 1996. Pseudomonas keratitis. The role of an uncharacterized exoproteins, protease IV, in corneal virulence. Invest. Ophthalmol. Vis. Sci., 37: 534-543.
Direct Link  |  

Pillar, M.C. and J.A. Hobden, 2002. Pseudomonas aeruginosa exotoxin A and keratitis in mice. Invest. Ophthalmol. Vis. Sci., 43: 1437-1444.
Direct Link  |  

Pillar, M.G., 2001. Pseudomonas aeruginosa exotoxin and ocular virulence. Ph.D. Thesis, Wayne State University, Detroit, Michigan, USA.

Rudner, X.L., K.A. Kernacki, R.P. Barrett and L.D. Hazlett, 2000. Prolonged elevation of IL-1 in Pseudomonas aeruginosa ocular infection regulates macrophage inflammatory protein-2 production, polymorphonuclear neutrophil persistence and corneal perforation. J. Immunol., 164: 6576-6582.

Schaad, U.B., A.B. Lang, J. Wedgwood, A. Ruedeberg, J.U. Que, E. Furer and S.J.J. Cryz, 1991. Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis. Lancet, 338: 1236-1237.
Direct Link  |  

Shiau, J.W., T.K. Tang, Y.L. Shih, C. Tai, Y.Y. Sung, J.L. Huang and H.L. Yang, 2000. Mice immunized with DNA encoding a modified Pseudomonas aeruginosa exotoxin A develop protective immunity against exotoxin intoxication. Vaccine, 19: 1106-1112.
CrossRef  |  

Sokol, P.A., C. Kooi, R.S. Hodges, P. Cachia and D.E. Woods, 2000. Immunization with a Pseudomonas aeruginosa elastase peptide reduces severity of experimental lung infections due to P.aeruginosa or Burkholderia cepacia. J. Infect. Dis., 181: 1682-1692.
Direct Link  |  

Thakur, A., J. Kyd, M. Xue, M.D.P. Willcox and A. Cripps, 2001. Effector mechanisum of protection against Pseudomonas aeruginosa keratitis in immunized rats. Infect. Immunity, 69: 3295-3304.
CrossRef  |  Direct Link  |  

Thomas, L.D., M.L. Dunkly, R. Moore, S. Reynolds, D.A. Bastin, J.M. Kyd and A.W. Cripps, 2000. Catalase immunization from Pseudomonas aeruginosa enhances bacterial clearance in the rat lung. Vaccine, 19: 348-357.
CrossRef  |  Direct Link  |  

Weimer, E.T., 2009. Development of flagellin-based multivalent vaccine against Pseudomonas aeruginosa. Ph.D. Thesis, Microbiology and Immunology, Winston-Salem, NC.

Wu, M., S.A. McClellan, R.P. Barrett, Y. Zhang and L.D. Hazlett, 2009. B-defensins 2 and 3 together promote resistance to Pseudomonas aeruginosa keratitis. J. Immunol., 183: 8054-8060.
Direct Link  |